Drug Therapy for Adults with Attention-Deficit Hyperactivity Disorder (Q35580455)

9 August 2017

1 reference

title

Drug therapy for adults with attention-deficit hyperactivity disorder (English)

1 reference

9 August 2017

Drug Therapy for Adults with Attention-Deficit Hyperactivity Disorder (English)

1 reference

10.2165/00003495-200363220-00002

Crossref

DOI

https://api.crossref.org/works/10.2165/00003495-200363220-00002

30 March 2024

1 reference

attention deficit hyperactivity disorder

1 reference

Timothy E. Wilens

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:14609347

30 March 2024

language of work or name

1 reference

1 January 2003

1 reference

9 August 2017

1 reference

9 August 2017

volume

63

1 reference

9 August 2017

issue

22

1 reference

9 August 2017

page(s)

2395-2411

1 reference

Stimulant drug treatment of hyperactivity: biochemical correlates.

9 August 2017

cites work

1 reference

12 December 2020

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies

1 reference

12 December 2020

An open trial of venlafaxine in adult patients with attention deficit hyperactivity disorder

1 reference

12 December 2020

Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association

1 reference

12 December 2020

Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status.

1 reference

12 December 2020

Amphetamine: effects on catecholamine systems and behavior

1 reference

12 December 2020

The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder

1 reference

12 December 2020

Evidence of lack of abuse or dependence following pemoline treatment: results of a retrospective survey

1 reference

12 December 2020

Age-dependent decline of attention deficit hyperactivity disorder

1 reference

12 December 2020

An open-label trial of tomoxetine in pediatric attention deficit hyperactivity disorder

1 reference

12 December 2020

Propranolol for adults with temper outbursts and residual attention deficit disorder.

1 reference

12 December 2020

Clinical correlates of methylphenidate blood levels.

1 reference

12 December 2020

Unrecognized attention-deficit hyperactivity disorder in adults presenting for outpatient psychotherapy.

1 reference

12 December 2020

Methylphenidate treatment for cocaine abusers with adult attention-deficit/hyperactivity disorder: a pilot study

1 reference

12 December 2020

Dopamine transporter density in patients with attention deficit hyperactivity disorder.

1 reference

12 December 2020

Case study: adverse effects of smoking marijuana while receiving tricyclic antidepressants

1 reference

12 December 2020

Attention deficit disorders in adults

1 reference

12 December 2020

Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder

1 reference

12 December 2020

Use of self-ratings in the assessment of symptoms of attention deficit hyperactivity disorder in adults.

1 reference

12 December 2020

Nicotinic systems and cognitive function

1 reference

12 December 2020

History of childhood attention deficit hyperactivity disorder (ADHD) features among adults with panic disorder

1 reference

12 December 2020

Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder.

1 reference

12 December 2020

Treatment of hyperactive children with monoamine oxidase inhibitors. I. Clinical efficacy

1 reference

12 December 2020

Hyperactive boys almost grown up. V. Replication of psychiatric status.

1 reference

12 December 2020

Replacement medication for cocaine dependence: methylphenidate.

1 reference

12 December 2020

Nicotine effects on adults with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Nicotine and attention in adult attention deficit hyperactivity disorder (ADHD)

1 reference

12 December 2020

A randomised, double-blind, placebo-controlled trial of dexamphetamine in adults with attention deficit hyperactivity disorder

1 reference

12 December 2020

Cognitive effects of nicotine

1 reference

12 December 2020

Bupropion SR vs. methylphenidate vs. placebo for attention deficit hyperactivity disorder in adults.

1 reference

12 December 2020

An open-label, dose-ranging study of atomoxetine in children with attention deficit hyperactivity disorder

1 reference

12 December 2020

Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder

1 reference

12 December 2020

An open trial of bupropion for the treatment of adults with attention-deficit/hyperactivity disorder and bipolar disorder

1 reference

12 December 2020

Dopamine D4 gene 7-repeat allele and attention deficit hyperactivity disorder

1 reference

12 December 2020

A systematic assessment of tricyclic antidepressants in the treatment of adult attention-deficit hyperactivity disorder

1 reference

12 December 2020

Comorbidity of attention deficit hyperactivity disorder with early- and late-onset bipolar disorder

1 reference

12 December 2020

Smoking, nicotine and human performance

1 reference

12 December 2020

Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography

1 reference

12 December 2020

Attention-Deficit Hyperactivity Disorder and Substance Abuse: Relationships and Implications for Treatment

1 reference

12 December 2020

Nicotine chewing gum (2 mg, 4 mg) and cigarette smoking: comparative effects upon vigilance and heart rate

1 reference

12 December 2020

Developmental change in attention-deficit hyperactivity disorder in boys: a four-year longitudinal study.

1 reference

12 December 2020

Controlled trial of high doses of pemoline for adults with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Rating scales in attention-deficit/hyperactivity disorder: use in assessment and treatment monitoring.

1 reference

12 December 2020

Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle

1 reference

12 December 2020

Bupropion treatment for cocaine abuse and adult attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Bupropion treatment of attention-deficit hyperactivity disorder in adults

1 reference

12 December 2020

A clinical and demographic profile of a sample of adults with attention deficit hyperactivity disorder, residual state

1 reference

12 December 2020

Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications

1 reference

12 December 2020

The neurobiology of attention-deficit/hyperactivity disorder.

1 reference

12 December 2020

Executive functions and developmental psychopathology

1 reference

12 December 2020

Response inhibition in AD/HD, CD, comorbid AD/HD CD, anxious, and control children: a meta-analysis of studies with the stop task.

1 reference

12 December 2020

Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study.

1 reference

12 December 2020

Treatment of narcolepsy: objective studies on methylphenidate, pemoline, and protriptyline

1 reference

12 December 2020

The stimulants revisited.

1 reference

12 December 2020

The effects of cigarettes of varying yield on rapid information processing performance

1 reference

12 December 2020

Methylphenidate and desipramine in hospitalized children: I. Separate and combined effects on cognitive function.

1 reference

12 December 2020

Attention deficit disorder ('minimal brain dysfunction') in adults. A replication study of diagnosis and drug treatment

1 reference

12 December 2020

A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults

1 reference

12 December 2020

Attention deficit disorder with hyperactivity and methylphenidate: the effects of dose and mastery level on children's learning performance.

1 reference

12 December 2020

A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder

1 reference

12 December 2020

Neuropharmacology of methylphenidate and a neural substrate for childhood hyperactivity

1 reference

12 December 2020

Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity

1 reference

12 December 2020

An open trial of pargyline in the treatment of attention deficit disorder, residual type

1 reference

12 December 2020

Diagnosis and treatment of minimal brain dysfunction in adults: a preliminary report

1 reference

12 December 2020

Treatment of ADHD in children with tics: a randomized controlled trial

1 reference

12 December 2020

Nomifensine maleate in adult attention deficit disorder

1 reference

12 December 2020

A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults

1 reference

12 December 2020

Attention deficit hyperactivity disorder in adults

1 reference

12 December 2020

Pemoline-associated hepatic failure: a critical analysis of the literature

1 reference

12 December 2020

Open-label trial of venlafaxine in adults with attention deficit disorder.

1 reference

12 December 2020

Toward defining a neuropsychology of attention deficit-hyperactivity disorder: performance of children and adolescents from a large clinically referred sample.

1 reference

12 December 2020

A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder.

1 reference

12 December 2020

Pharmacological treatment of attention deficit disorder, residual type (ADD,RT, "minimal brain dysfunction," "hyperactivity") in adults

1 reference

12 December 2020

Differential effects of methylphenidate and dextroamphetamine on the motor activity level of hyperactive children

1 reference

12 December 2020

Low-dose amphetamine salts and adult attention-deficit/hyperactivity disorder.

1 reference

12 December 2020

Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type.

1 reference

12 December 2020

Effects of levodopa on attention deficit disorder, residual type

1 reference

12 December 2020

Combination of treatments for attention deficit hyperactivity disorder in adults.

1 reference

12 December 2020

Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate

1 reference

12 December 2020

Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease.

1 reference

12 December 2020

An open trial of L-tyrosine in the treatment of attention deficit disorder, residual type

1 reference

12 December 2020

Adults with attention-deficit/hyperactivity disorder: a controversial diagnosis.

1 reference

12 December 2020

Venlafaxine in adults with attention-deficit/hyperactivity disorder: an open clinical trial

1 reference

12 December 2020

Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature

1 reference

12 December 2020

Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder

1 reference

12 December 2020

Methylphenidate effects on symptoms of attention deficit disorder in adults.

1 reference

12 December 2020

Treatment of attention deficit disorder with DL-phenylalanine

1 reference

12 December 2020

Attention deficit hyperactivity disorder in childhood among adults with major depression

1 reference

12 December 2020

Selegiline in adults with attention deficit hyperactivity disorder: clinical efficacy and safety

1 reference

12 December 2020

S-adenosyl-L-methionine (SAM) in adults with ADHD, RS: preliminary results from an open trial

1 reference

12 December 2020

Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study

1 reference

12 December 2020

Six-year predictors of problems in a national sample: IV. Young adult signs of disturbance

1 reference

12 December 2020

Fluoxetine and methylphenidate in combination for treatment of attention deficit disorder and comorbid depressive disorder

1 reference

12 December 2020

American Journal of Psychiatry

41

156

1931

Wilens

1999

1 reference

10.2165/00003495-200363220-00002

Crossref

DOI

https://api.crossref.org/works/10.2165/00003495-200363220-00002

10.2165/00003495-200363220-00002

30 March 2024

Identifiers

DOI

1 reference

Dimensions Publication ID

9 August 2017

1051804597

0 references

1 reference